Author Schanz, Julie

• 2006 | Conference Abstract
  ​ ​New and comprehensive cytogenetic prognostication and categorization in MDS.​
  Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Noesslinger, T.; Hildebrandt, B. & Kuendgen, A. et al.​ (2006)
  Blood, 108(11) ​48th Annual Meeting of the American-Society-of-Hematology​, Orlando, FL.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2006 | Conference Abstract
  ​ ​Evidence for an underestimation of the prognostic impact of poor cytogenetics within the IPSS.​
  Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Hildebrandt, B.; Luebbert, M. & Giagounidis, A. A. N. et al.​ (2006)
  Blood, 108(11) , Orlando, FL.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2007 | Conference Abstract
  ​ ​FISH-Analyses of cirulating CD34+cells in MDS-Patients - A suitable method to measure and predict response to 5-azacytidinie.​
  Braulke, F.; Schanz, J.; Steidl, C.; Truemper, L. H. & Haase, D.​ (2007)
  Blood, 110(11) pp. 727A​-728A. ​49th Annual Meeting of the American-Society-of-Hematology​, Atlanta, GA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2007 | Journal Article
  ​ ​New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients​
  Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Noesslinger, T.; Hildebrandt, B. & Kundgen, A. et al.​ (2007) 
  Blood, 110(13) pp. 4385​-4395​.​ DOI: https://doi.org/10.1182/blood-2007-03-082404 
  ​Details  DOI  PMID  PMC  WoS 

• 2008 | Conference Abstract
  ​ ​New Prognostic Data on Rare Cytogenetic Abnormalities in MDS: A Collaborative Study of the International Working Group on MDS Cytogenetics.​
  Schanz, J.; Slovak, M. L.; Ohyashiki, K.; Sole, F.; del Mar Mallo, M.; Steidl, C. & Pfeilstoecker, M. et al.​ (2008)
  Blood, 112(11) pp. 929​-930. ​50th Annual Meeting of the American-Society-of-Hematology​, San Francisco, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2008 | Conference Abstract
  ​ ​Analysing Circulating CD34+Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities.​
  Braulke, F.; Schanz, J.; Truemper, L. H. & Haase, D.​ (2008)
  Blood, 112(11) pp. 932​-933. ​50th Annual Meeting of the American-Society-of-Hematology​, San Francisco, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2008 | Conference Abstract
  ​ ​Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q-in Patients with primary Myelodysplastic Syndrome​
  Del Mar Mallo, M.; Cervera, J.; Schanz, J.; Espinet, B.; Such, E.; Luno, E. & Steidl, C. et al.​ (2008)
  Blood, 112(11) ​50th Annual Meeting of the American-Society-of-Hematology/ASH/ASCO Joint Symposium​, San Francisco, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2009 | Conference Abstract
  ​ ​Cytogenetic Risk Features in MDS-Update and Present State.​
  Schanz, J.; Tuechler, H.; Sole, F.; Mallo, M.; Hildebrandt, B.; Slovak, M. L. & Ohyashiki, K. et al.​ (2009)
  Blood, 114(22) ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2009 | Conference Abstract
  ​ ​Survival, Prognostic Factors, and Rates of Leukemic Transformation in a Multicenter Study of 303 Untreated Patients with MDS and Del(5q)​
  Germing, U.; Lauseker, M.; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Pfeilstoecker, M. & Noesslinger, T. et al.​ (2009)
  Blood, 114(22) pp. 390​-391. ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2009 | Journal Article
  ​ ​Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes​
  Schanz, J.; Jung, H.; Woermann, B.; Gassmann, W.; Petersen, T.; Hinke, A. & Haase, D.​ (2009) 
  Leukemia Research, 33(9) pp. 1183​-1188​.​ DOI: https://doi.org/10.1016/j.leukres.2009.03.027 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article
  ​ ​FISH analysis of circulating CD34+cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients​
  Braulke, F.; Schanz, J.; Jung, K.; Shirneshan, K.; Schulte, K.; Schuetze, C. & Steffens, R. et al.​ (2010) 
  Leukemia Research, 34(10) pp. 1296​-1301​.​ DOI: https://doi.org/10.1016/j.leukres.2010.01.010 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Conference Abstract
  ​ ​Genetic Response to Lenalidomide in the Circulating Progenitor Cell Compartment of MDS Cohort. Preliminary Results of the Multicenter German LE-MON-5 Study​
  Shirneshan, K.; Germing, U.; Braulke, F.; Schanz, J.; Platzbecker, U.; Giagounidis, A. A. N. & Nolte, F. et al.​ (2011)
  Blood, 118(21) ​53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis​, San Diego, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2011 | Conference Abstract
  ​ ​Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+and CD3+Peripheral Blood Cells​
  Ganster, C.; Braulke, F.; Shirneshan, K.; Kaempfe, D.; Platzbecker, U.; Soeling, U. & Bramlage, C. P. et al.​ (2011)
  Blood, 118(21) pp. 1623​-1624. , San Diego, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2011 | Journal Article
  ​ ​Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System​
  Schanz, J.; Steidl, C.; Fonatsch, C.; Pfeilstoecker, M.; Noesslinger, T.; Tuechler, H. & Valent, P. et al.​ (2011) 
  Journal of Clinical Oncology, 29(15) pp. 1963​-1970​.​ DOI: https://doi.org/10.1200/JCO.2010.28.3978 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Journal Article | Letter Note
  ​ ​Two different del(5q) clones in a patient with myelodysplastic syndrome​
  Braulke, F.; Schanz, J.; Steffens, R.; Liehr, T.; Manvelyan, M.; Chudoba, I. & Haase, D.​ (2011) 
  Leukemia & Lymphoma, 52(9) pp. 1811​-1814​.​ DOI: https://doi.org/10.3109/10428194.2011.575968 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Journal Article | 
  ​ ​Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid​
  Kuendgen, A.; Bug, G.; Ottmann, O. G.; Haase, D.; Schanz, J.; Hildebrandt, B. & Nachtkamp, K. et al.​ (2011) 
  Clinical Epigenetics, 2 pp. 389​-399​.​ DOI: https://doi.org/10.1007/s13148-011-0031-9 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Conference Abstract
  ​ ​A Comprehensive Genetic Analysis of MDS Patients From Peripheral Blood Combining FISH- and SNP-Array-Analysis​
  Ganster, C.; Shirneshan, K.; Salinas-Riester, G.; Braulke, F.; Schanz, J.; Goetze, K. S. & Bug, G. et al.​ (2012)
  Blood, 120(21) ​54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)​, Atlanta, GA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2012 | Journal Article | Letter Note
  ​ ​Cytogenetic Risk Stratification in Myelodysplastic Syndromes: Are We There Yet? Reply​
  Schanz, J. & Haase, D.​ (2012) 
  Journal of Clinical Oncology, 30(21) pp. 2704​-2706​.​ DOI: https://doi.org/10.1200/JCO.2012.43.8267 
  ​Details  DOI  WoS 

• 2012 | Journal Article
  ​ ​New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge​
  Schanz, J.; Tuechler, H.; Sole, F.; Mallo, M.; Luno, E.; Cervera, J. & Granada, I. et al.​ (2012) 
  Journal of Clinical Oncology, 30(8) pp. 820​-829​.​ DOI: https://doi.org/10.1200/JCO.2011.35.6394 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Journal Article
  ​ ​Revised International Prognostic Scoring System for Myelodysplastic Syndromes​
  Greenberg, P. L.; Tuechler, H.; Schanz, J.; Sanz, G. F.; Garcia-Manero, G.; Sole, F. & Bennett, J. M. et al.​ (2012) 
  Blood, 120(12) pp. 2454​-2465​.​ DOI: https://doi.org/10.1182/blood-2012-03-420489 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article
  ​ ​Molecular cytogenetic monitoring from CD34+peripheral blood cells in myelodysplastic syndromes: First results from a prospective multicenter German diagnostic study​
  Braulke, F. ; Jung, K.; Schanz, J.; Götze, K. S.; Müller-Thomas, C.; Platzbecker, U. & Germing, U. et al.​ (2013) 
  Leukemia Research, 37(8) pp. 900​-906​.​ DOI: https://doi.org/10.1016/j.leukres.2013.03.019 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Conference Abstract
  ​ ​Multi-Center Study on Myelodysplastic Syndromes with Isolated Partial or Total Loss of Chromosome 7​
  Crisa, E.; Such, E.; Best, S.; Kulasekararaj, A.; Cervera, J.; Adema, V. & Lea, N. et al.​ (2014)
  Blood, 124(21) 
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2014 | Conference Abstract
  ​ ​Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R​
  Schanz, J.; Braulke, F.; Mufti, G. J.; Crisa, E.; Kulasekararaj, A.; Nachtkamp, K. & Germing, U. et al.​ (2014)
  Blood, 124(21) ​56th Annual Meeting of the American-Society-of-Hematology​, San Francisco, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2014 | Journal Article | Letter Note | 
  ​ ​Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia​
  Mueller-Thomas, C.; Rudelius, M.; Rondak, I.-C.; Haferlach, T.; Schanz, J.; Huberle, C. & Schmidt, B. C. et al.​ (2014) 
  Haematologica, 99(10) pp. E179​-E181​.​ DOI: https://doi.org/10.3324/haematol.2014.104760 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Conference Abstract
  ​ ​Prognostic Impact of Rare Single Abnormalities in Myelodysplastic Syndromes​
  Schanz, J.; Tuechler, H.; Sole, F.; Sanz, G. F.; Garcia-Manero, G.; Le Beau, M. M. & Bennett, J. M. et al.​ (2015)
  Blood, 126(23) ​57th Annual Meeting of the American-Society-of-Hematology​, Orlando, FL.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2015 | Journal Article
  ​ ​Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS​
  Ganster, C.; Shirneshan, K.; Salinas-Riester, G.; Braulke, F.; Schanz, J.; Platzbecker, U. & Haase, D.​ (2015) 
  Leukemia Research, 39(10) pp. 1079​-1087​.​ DOI: https://doi.org/10.1016/j.leukres.2015.06.011 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​New Data Shed Light on Y-Loss-Related Pathogenesis in Myelodysplastic Syndromes​
  Ganster, C.; Kaempfe, D.; Jung, K.; Braulke, F.; Shirneshan, K.; Machherndl-Spandl, S. & Suessner, S. et al.​ (2015) 
  Genes Chromosomes and Cancer, 54(12) pp. 717​-724​.​ DOI: https://doi.org/10.1002/gcc.22282 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Frequency of del(12p) is Commonly Underestimated in Myelodysplastic Syndromes: Results from a German Diagnostic Study in Comparison with an International Control Group​
  Braulke, F.; Mueller-Thomas, C.; Goetze, K. S.; Platzbecker, U.; Germing, U.; Hofmann, W.-K. & Giagounidis, A. A. N. et al.​ (2015) 
  Genes Chromosomes and Cancer, 54(12) pp. 809​-817​.​ DOI: https://doi.org/10.1002/gcc.22292 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Primary osteomyelofibrosis and an XX-male genotype​
  Schanz, J.; Haase, D.; Steuernagel, P.; Shirneshan, K.   & Baesecke, J.​ (2015) 
  European Journal Of Haematology, 95(3) pp. 254​-256​.​ DOI: https://doi.org/10.1111/ejh.12555 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.​
  Braulke, F.; Platzbecker, U.; Müller-Thomas, C.; Götze, K.; Germing, U.; Brümmendorf, T. H. & Nolte, F. et al.​ (2015) 
  Haematologica, 100(2) pp. 205​-213​.​ DOI: https://doi.org/10.3324/haematol.2014.110452 
  ​Details  DOI  PMID  PMC 

• 2016 | Journal Article | Letter Note
  ​ ​Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes​
  Greenberg, P. L.; Tuechler, H.; Schanz, J.; Sanz, G. F.; Garcia-Manero, G.; Sole, F. & Bennett, J. M. et al.​ (2016) 
  Blood, 128(16) pp. 2096​-2097​.​ DOI: https://doi.org/10.1182/blood-2016-07-728766 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Time-dependent changes in mortality and transformation risk in MDS​
  Pfeilstoecker, M.; Tuechler, H.; Sanz, G. F.; Schanz, J.; Garcia-Manero, G.; Sole, F. & Bennett, J. M. et al.​ (2016) 
  Blood, 128(7) pp. 902​-910​.​ DOI: https://doi.org/10.1182/blood-2016-02-700054 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article | 
  ​ ​Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions​
  Valent, P.; Orazi, A.; Steensma, D. P.; Ebert, B. L.; Haase, D.; Malcovati, L. & van de Loosdrecht, A. A. et al.​ (2017) 
  Oncotarget, 8(43) pp. 73483​-73500​.​ DOI: https://doi.org/10.18632/oncotarget.19008 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article
  ​ ​Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS​
  Miyazaki, Y.; Tuechler, H.; Sanz, G.; Schanz, J.; Garcia-Manero, G.; Solé, F. & Bennett, J. M. et al.​ (2018) 
  Leukemia Research, 73 pp. 51​-57​.​ DOI: https://doi.org/10.1016/j.leukres.2018.08.022 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome​
  Dickel, S.; Grimm, C.; Amschler, K.; Schnitzler, S. U.; Schanz, J.; Moerer, O. & Payen, D. et al.​ (2021) 
  Frontiers in Immunology, 12.​ DOI: https://doi.org/10.3389/fimmu.2021.645124 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices​
  Dierks, S.; Andag, R.; Gauss, F.; Budde, K.; Francke, P.; Peschka, M. & Fischer, A. et al.​ (2022) 
  Clinical Chemistry and Laboratory Medicine (CCLM), 0(0).​ DOI: https://doi.org/10.1515/cclm-2022-0054 
  ​Details  DOI 

• 2022 | Journal Article | 
  ​ ​Comparison and Harmonization of Different Semi-Automated and Automated qRT-PCR Assays in the Assessment of SARS-CoV-2​
  Dierks, S.; Thiele, K.; Bohne, W.; Lugert, R.; Weig, M.; Groß, U. & von Ahsen, N. et al.​ (2022) 
  Viruses, 14(10) pp. 2239​.​ DOI: https://doi.org/10.3390/v14102239 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Evaluation of a novel, stand-alone system to measure interleukin-6​
  Dierks, S.; Wiederhold, M.; Schanz, J.; Fischer, A. & Schnelle, M.​ (2023) 
  Clinical Chemistry and Laboratory Medicine,.​ DOI: https://doi.org/10.1515/cclm-2022-1320 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Methotrexate Drug Monitoring From Central Access: Can Blood Sample Collection From Central Venous Access Replace Peripheral Venipuncture in Adults?​
  Aydilek, E.; Schanz, J. & Brökers, N.​ (2023) 
  Therapeutic Drug Monitoring,.​ DOI: https://doi.org/10.1097/FTD.0000000000001080 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Cytogenetic peripheral blood monitoring in azacitidine treated patients with high-risk MDS/sAML: A monocentric real-world experience​
  Braulke, F.; Schweighöfer, A.; Schanz, J.; Shirneshan, K.; Ganster, C.; Pollock-Kopp, B. & Leha, A. et al.​ (2023) 
  Leukemia Research, 124 art. 106996​.​ DOI: https://doi.org/10.1016/j.leukres.2022.106996 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria​
  Prinz, C.; Streit, F.; Schumann, C.; Dudakova, A.; Lanckohr, C.; Schanz, J. & Bohn, M. et al.​ (2023) 
  Clinical Drug Investigation, 43(4) pp. 307​-314​.​ DOI: https://doi.org/10.1007/s40261-023-01257-8 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome​
  Treiber, H.; Ganster, C.; Schanz, J.; Shimono, J.; Zechel, S.; Pohanyar, N. & Riedel, C. et al.​ (2023) 
  Annals of Hematology,.​ DOI: https://doi.org/10.1007/s00277-023-05430-z 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Humoral and cellular immune responses in fully vaccinated individuals with or without SARS‐CoV‐2 breakthrough infection: Results from the CoV‐ADAPT cohort​
  Hollstein, M. M.; Dierks, S.; Schön, M. P.; Bergmann, A.; Abratis, A.; Eidizadeh, A. & Kaltenbach, S. et al.​ (2023) 
  Journal of Medical Virology, 95(10) art. e29122​.​ DOI: https://doi.org/10.1002/jmv.29122 
  ​Details  DOI 

Researcher

Sort

Items per Page